Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?
BMC Medicine 2013, 11:76 (20 March 2013)
Dyskinesia is a major complication in the treatment of Parkinson’s Disease; Christian Duval and colleagues propose a new approach to manage the level and type of these motor symptoms and help improve patients’ quality of life
Clinical application of stem cell therapy in Parkinson's disease
BMC Medicine 2012, 10:1 (4 January 2012)
This article is part of a collection on
Focus on stem cells
Politis and Lindvall review the evidence from clinical trials of human foetal ventral mesencephalic transplantation to treat Parkinson's disease (PD) patients, and review the current status of stem cell therapy, both of which aim to provide long-lasting relief of patients' symptoms.